0102030405
Acalabrutinib CAS No. 1420477-60-6 Pharmaceutical Intermediates
01
Introduction to Acalabrutinib
7 Jan 2019
Acalabrutinib is a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, extensively used in the pharmaceutical industry for the treatment of various types of cancer, particularly B-cell malignancies. As an integrated production and trade factory, we ensure the highest standards of quality and reliability in the manufacturing and supply of this critical therapeutic agent. Our commitment to excellence and customer satisfaction makes us a trusted partner for pharmaceutical companies worldwide.
02
Physical and Chemical Properties
7 Jan 2019
Acalabrutinib, with the molecular formula C26H23N7O2, is a white to off-white crystalline powder. It has a molecular weight of 465.51 g/mol. The compound exhibits excellent stability under standard storage conditions, ensuring a long shelf life and consistent performance in various applications.
Molecular Formula: C26H23N7O2
Molecular Weight: 465.51 g/mol
Appearance: White to off-white crystalline powder
Melting Point: 220-225°C
Solubility: Soluble in DMSO, ethanol, and other organic solvents
03
Advantages of Acalabrutinib
7 Jan 2019
1. High Purity and Consistent Quality: Our Acalabrutinib is produced using advanced manufacturing techniques, ensuring a high degree of purity and consistent quality. This makes it ideal for use in sensitive pharmaceutical applications.
2. Reliable Supply: As an integrated production and trade factory, we have complete control over the manufacturing process, from raw material procurement to final product delivery. This ensures a reliable and uninterrupted supply of Acalabrutinib to our customers.
3. Superior Stability: The compound's excellent physical and chemical stability ensures that it remains effective and reliable throughout its shelf life, providing consistent results in pharmaceutical formulations.
4. Competitive Pricing: Our efficient production processes and economies of scale allow us to offer Acalabrutinib at competitive prices, providing excellent value for our customers.
5. Exceptional Customer Support: We pride ourselves on our customer-centric approach, offering comprehensive support and technical assistance to ensure the successful application of our products in your pharmaceutical projects.
04
Applications in the Pharmaceutical Industry
7 Jan 2019
Acalabrutinib is a crucial therapeutic agent in the treatment of various types of cancer, particularly B-cell malignancies such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Its unique mechanism of action and high selectivity make it an essential component in targeted cancer therapy. The compound is used in the development of:
Targeted Cancer Therapies: Acalabrutinib is a key component in the development of targeted cancer therapies, providing effective treatment options for patients with B-cell malignancies.
Combination Therapies: The compound is utilized in combination with other therapeutic agents to enhance the efficacy of cancer treatments and improve patient outcomes.
Clinical Research: Acalabrutinib is extensively used in clinical research to explore new therapeutic applications and improve existing treatment protocols for various types of cancer.
04
Conclusion
7 Jan 2019
Acalabrutinib is an indispensable therapeutic agent in the pharmaceutical industry, offering high purity, superior stability, and reliable performance. As an integrated production and trade factory, we are committed to providing our customers with the highest quality products and unparalleled support. Partner with us for your pharmaceutical synthesis needs and experience the benefits of our expertise and dedication to excellence.
description2